BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
BAP
Credicorp Ltd.
BAP has a slight edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BAP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAP's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAP.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BAP in the historical PE scenario, which offers more potential upside but is not a forecast.
BAP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.5x | $258 | -29% |
| Fair | 11x | $303 | -17% |
| Current | 13x | $365 | — |
| Expensive | 18x | $478 | +31% |
Historical ranges are pointers, not guarantees.
BAP's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BAP on the outlook, with more favorable profitability expectations.
BAP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BAP, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
BAP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $27.11 | +18% |
| Q1 2026 | $26.53 | +25% |
| Q4 2025 | $25.50 | +26% |
| Q3 2025 | $23.81 | +24% |
| Q2 2025 | $23.02 | +27% |
| Q1 2025 | $21.27 | +16% |
| Q4 2024 | $20.28 | +13% |
| Q3 2024 | $19.24 | +2.6% |
BAP has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over BAP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BAP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.4B | +9.3% |
| Q1 2026 | $2.3B | +12% |
| Q4 2025 | $2.4B | +26% |
| Q3 2025 | $1.6B | -23% |
| Q2 2025 | $2.2B | +8.9% |
| Q1 2025 | $2B | +5.6% |
| Q4 2024 | $1.9B | +2.3% |
| Q3 2024 | $2B | +5.4% |
BAP's revenue has picked up after two years of holding roughly level: $2.4B last quarter, up 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 35% | +0.2 points |
| Q1 2026 | 38% | +1.3 points |
| Q4 2025 | 28% | +1.6 points |
| Q3 2025 | 51% | +20 points |
| Q2 2025 | 35% | +6.8 points |
| Q1 2025 | 36% | +4.8 points |
| Q4 2024 | 27% | +6.6 points |
| Q3 2024 | 31% | +4.3 points |
BAP has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BAP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.3B | -25% |
| Q1 2026 | -$276.5M | -211% |
| Q4 2025 | -$186.3M | +$1.1B |
| Q3 2025 | $652.6M | +$652.6M |
| Q2 2025 | $1.8B | +$1.8B |
| Q1 2025 | $249.8M | +$249.8M |
| Q4 2024 | -$1.3B | -333% |
| Q3 2024 | $0 | -100% |
BAP's free cash flow was $1.5B over the past year, up 122% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAP.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BAP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BAP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -48.7K shares |
| 1 year | -0.6% | -486K shares |
| 3 years | -0.4% | -326K shares |
| 5 years | -0.4% | -319K shares |
| Available history | -0.3% | -223K shares |
BAP has 79M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $10.5M |
| Q1 2026 | $8.1M |
| Q4 2025 | $1.5M |
| Q3 2025 | $1.1M |
| Q2 2025 | — |
| Q1 2025 | $35M |
| Q4 2024 | — |
| Q3 2024 | — |
BAP has spent almost nothing on buybacks in the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BAP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
| Q3 2024 | -0.9x | Net Cash |
BAP has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BAP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.2 | Neutral |
| Stochastic | 20.6 | Neutral |
BAP's weekly RSI is 50 (neutral) and its Stochastic is 21 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BAP on valuation relative to its sector.
BAP PE vs Financial Services Sector
| Metric | BAP | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 3.5% above |
| PE % | 70 | 63 | 7 pts above |
BAP is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BAP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $370.4 | 1.4% below |
| 20 week MA | $379.9 | 3.8% below |
| 50 week MA | $349.4 | 4.6% above |
| 100 week MA | $284.1 | 29% above |
| 200 week MA | $218.9 | 67% above |
BAP has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BAP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.3 | $165.0 | -23% |
| 2021 | $165.0 | $119.9 | -27% |
| 2022 | $119.9 | $134.7 | +12% |
| 2023 | $134.7 | $149.9 | +11% |
| 2024 | $149.9 | $181.1 | +21% |
| 2025 | $181.1 | $291.5 | +61% |
| 2026 YTD | $291.5 | $365.4 | +25% |
BAP has the edge over BAC on returns for 2026, with the stronger performance.